By one year, it has produced roughly 40 to 50 percent more weight loss than semaglutide
Other TRIUMPH Trials Additional Phase 3 trials in the TRIUMPH program are ongoing: TRIUMPH-1: Retatrutide in obesity (general population), results expected 2026 TRIUMPH-2: Retatrutide in type 2 diabetes, results expected 2026 TRIUMPH-3: Retatrutide cardiovascular outcomes trial, results expected 2027 Visualize Your Retatrutide Journey See how retatrutide builds up in your system over time and compare different dosing protocols
Hydration tips that double as oral-care support Because saliva volume tracks closely with fluid status, the hydration guidance you follow for treatment comfort also supports oral health
At least in the US, the numbers are truly staggering with c 44% of people belonging in the obese or overweight group, which could increase to 53% by the end of the decade
This daily oral supplement delivers whitening, brightening, and antioxidant benefits through a proven combination of ingredients that help defend, renew, and transform skinwithout added steps in your daily skincare routine